Evidence map›Paper›PMID 42098792›Full record

ArticleBiotechnology for biofuels and bioproducts2026

Engineering artificial microbial consortia for efficient lactic acid fermentation from undetoxified hydrolysates: from induced niche succession in a dual Bacillus coagulans consortium to Pseudomonas putida-assisted system reinforcement.

Jiaming Fu, Shuiping Ouyang, Shuai Liang, Chang Yu, Yuxuan Wu, Hongxiao Li, Zhaojuan Zheng, Jia Ouyang

Abstract read
In one paragraph

Article in Biotechnology for biofuels and bioproducts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiaming Fu *State Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China.
Shuiping Ouyang *College of Advanced Materials Engineering, Jiaxing Nanhu University, Jiaxing, 314001, Zhejiang, China.
Shuai LiangState Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China.
Chang YuState Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China.
Yuxuan WuState Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China.
Hongxiao LiState Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China.
Zhaojuan ZhengState Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China.
Jia OuyangState Key Laboratory for Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing, People's Republic of China. hgouyj@njfu.edu.cn.

Funding

National Key Research and Development Program of China 2018YFA0902200National Natural Science Foundation of China 32201191
6 · The paper itself

Abstract

backgroundLignocellulosic biomass represents an ideal feedstock for biochemical production as a sustainable alternative to fossil resources. However, high concentrations of inhibitors inevitably generated during pretreatment-particularly phenolic compounds-severely impede microbial growth and metabolism, representing a major bottleneck in biorefining. In contrast to expensive physicochemical detoxification or single-strain strategies burdened by heavy metabolic loads, microbial co-culture systems employing division of labor offer a highly efficient and cost-effective novel pathway.

resultsThis study developed a novel dual Bacillus coagulans co-culture system consisting of a phenolic acid decarboxylase (PAD)-overexpressing engineered strain, DSM1-25280, and a high-yield L-lactic acid (LA) producer, CC17B-1, capable of directly utilizing highly toxic lignocellulosic hydrolysates for high-titer LA production. Notably, overexpression of PAD in the engineered strain DSM1-25280 not only enhanced tolerance to phenolic acids but also significantly accelerated vanillin degradation. By establishing a sequential inoculation strategy and optimizing both inoculation ratios and intervals, the dual-strain system achieved a LA titer of 124.72 g/L from undetoxified corncob hydrolysates. Multidimensional association analysis suggested a strongly supported model of niche succession process within the system, transitioning from biodetoxification-mediated commensalism to competitive exclusion. Furthermore, we constructed an enhanced three-strain co-culture system by incorporating a sugar-metabolism-deficient engineered Pseudomonas putida KT2440 ZL as a heterologous aromatic scavenger. This system further elevated the LA titer to 146.00 g/L with a yield of 98.9%, ranking among the highest levels reported to date for LA production from undetoxified hydrolysates.

conclusionsThe constructed microbial co-culture system significantly enhances LA fermentation performance using undetoxified lignocellulosic hydrolysates, bypassing the need for physicochemical detoxification. Demonstrating exceptional modularity and robustness, this sequential co-culture strategy effectively overcomes the toxicity bottlenecks inherent in traditional bioconversion processes. Ultimately, this work not only validates the superiority of division of labor in valorizing complex feedstocks but also provides a novel approach for the efficient biomanufacturing of high-value chemicals from low-grade biomass.

Indexed as

Artificial microbial co-culture systemBacillus coagulansInduced niche successionLignocellulosic hydrolysatesL-lactic acid

Identifiers

PMID42098792
PMCPMC13321670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.